XML 44 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Accounting Policies - Additional Information (Details) - USD ($)
12 Months Ended
Jan. 01, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Jan. 01, 2018
Significant Accounting Policies [Line Items]          
Revenue recognized related to the advance from Healios   $ 0      
Accrued capital expenditures   100,000   $ 100,000  
Available for sale securities   0 $ 0 0  
Realized gains and losses   0 0 0  
Payments for royalties   0 0 0  
Sublicense fees   600,000   300,000  
Gain from insurance proceeds, net   617,000 0 682,000  
Warrant liabilities   $ 0 0    
Contractual term   10 years      
Liability for uncertain income tax   $ 0 0    
Dilutive effects from warrant liabilities   0 0 $ 0  
Healios License Agreement          
Significant Accounting Policies [Line Items]          
Unbilled accounts receivable from Healios   3,620,000 0    
Deposit from Healios   $ 2,000,000 $ 0    
Minimum          
Significant Accounting Policies [Line Items]          
Estimated useful life of long-lived assets   3 years      
Annual stock-based awards vesting period   3 years      
Maximum          
Significant Accounting Policies [Line Items]          
Estimated useful life of long-lived assets   10 years      
Annual stock-based awards vesting period   4 years      
License | Healios License Agreement          
Significant Accounting Policies [Line Items]          
Unbilled accounts receivable from Healios   $ 2,500,000      
Retained Earnings | ASU 2014-09          
Significant Accounting Policies [Line Items]          
Cumulative effect adjustment recognized         $ 1,900,000
Forecast | Subsequent Event | ASU 2016-02          
Significant Accounting Policies [Line Items]          
Percentage of total assets (less than) 2.00%